• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA ETEST® DAPTOMYCIN DPC 256 WW S30

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA ETEST® DAPTOMYCIN DPC 256 WW S30 Back to Search Results
Catalog Number 412324
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
A customer in (b)(6) reported a daptomycin qc (atcc 29212 tm) failure oorl (out of range low) for enterococcus faecalis when tested with the etest daptomycin kit.Expected mic value is 1 - 4 g/ml; results obtained were 0.5 g/ml and 0.75 g/ml.There is no indication or report from the hospital to biomerieux that the daptomycin qc failure led to any adverse event related to a patient's state of health.There is no patient directly associated with the qc sample.Culture submittals have been requested by biomerieux for internal investigation.An internal biomerieux investigation will be initiated.
 
Manufacturer Narrative
This report was initially submitted following notification that a customer in (b)(6)reported occurrence of a low mic result for enterococcus faecalis atcc® 29212¿ in association with the etest® daptomycin kit.Biomérieux investigation was conducted.Expected values: 1-4 g/ml.Customer results: between (b)(6) 2016, four (4) results at 0.5 g/ml on twelve (12) data.Four (4) data at 0.75 g/ml are acceptable - instruction for use 9302553c indicates: an etest® mic value which falls between standard two-fold dilutions must be rounded up to the next upper two-fold value before categorization.The customer did not submit test strips for investigational testing.Retained samples (customer batches 1004340160 and 1004093520) were tested, in parallel with another batch as reference.The investigation did not reproduce the issue observed by the customer with the quality control strains.The conformity of this batch was confirmed with three (3) qc atcc® strains: atcc® 29212¿ enterococcus feacalis, atcc® 29213¿ staphylococcus aureus and atcc® 49619¿ streptococcus pneumoniae.The investigation concluded the etest® daptomycin kit is performing as intended.As the customer product was not submitted for internal biomérieux testing, it can be hypothesized: media: - as explained in cis 014 or 9302553c, daptomycin requires physiologic levels of calcium (ca2+) for expression of adequate activity.The bioavailable free ca2+ levels in brands and batches of mha powder and commercial mha plates can vary significantly and affect etest® dpc results.- use only mha plates with consistent and appropriate ca2+ levels (25-40 g/ml).- perform quality control (qc) using both enterococcus faecalis atcc® 29212¿ (1-4) and staphylococcus aureus atcc® 29213¿ (0.25-1 [ g/ml).Use of two qc strains allows verification of results within the susceptible range and around the breakpoint.When results are out of qc specifications or consistently skewed at the limits, repeat the test using a different brand of mha.Reading: the investigation observed microcolonies with enterococcus feacalis atcc® 29212¿.=> read different etest® mic endpoint patterns using the etest® reading guidelines = cis014.In this case, read where the microcolonies are inhibited.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETEST® DAPTOMYCIN DPC 256 WW S30
Type of Device
ETEST® DAPTOMYCIN
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme les grottes isere, 38390
FR  38390
Manufacturer (Section G)
BIOMERIEUX, SA
3 route de port michaud
la balme les grottes isere, 38390
FR   38390
Manufacturer Contact
ryan lemelle
595 anglum road
hazelwood, MO 63042
3147318582
MDR Report Key5636742
MDR Text Key44595490
Report Number3002769706-2016-00087
Device Sequence Number1
Product Code JWY
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K042392
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/27/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/06/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/01/2018
Device Catalogue Number412324
Device Lot Number1004340160
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/27/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/02/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-